*Limitations apply. This offer is not valid under Medicare, Medicaid, or any other federal or state program, for cash-paying patients, or for Massachusetts residents. Patient pays first $10 co-pay on a 30-day supply, and the program will pay up to $10,630 per 30-day supply up to an annual max of $30,000. Novartis reserves the right to rescind, revoke, or amend this program without notice. For the most up-to-date terms and conditions, visit Terms and Conditions or call 1-866-GLEEVEC (453-3832).
Our patient counselors at the GLEEVEC Patient Support program can help these patients discover the programs that they may be eligible for. Please have your patients call 1-866-GLEEVEC (453-3832) for more information.
*For more detailed study information, please see full Prescribing Information.
†Numbers indicate the range of percentages in 4 studies among patients with newly diagnosed Ph+ CML, patients in blast crisis, in accelerated phase, and in the chronic phase after failure of interferon-alpha therapy.